Leading Growth Driver in the Cardiac Prosthetic Devices Market in 2025: Rising Cardiovascular Disease Rates Drive Growth in Cardiac Prosthetic Devices Driver's Influence

Which drivers are expected to have the greatest impact on the over the cardiac prosthetic devices market's growth?
The cardiac prosthetic devices market's expansion is anticipated to be fueled by the rising prevalence of cardiovascular diseases. Cardiovascular diseases (CVDs) encompass a broad set of disorders that impact the heart and blood vessels-these include conditions like heart attacks, coronary artery disease, and strokes. The surge in cardiovascular diseases is largely attributed to factors like unhealthy lifestyles, obesity rates, improper diet, insufficient physical activity, excessive stress, and an ageing populace. Cardiac prosthetic devices are pivotal in managing cardiovascular diseases as they assist or substitute the function or components of the heart. For example, data released by the British Heart Foundation-a charitable organization for cardiovascular research based in the UK-in January 2024 revealed that approximately 7.6 million people in the UK suffer from heart and circulatory diseases. This includes approximately 4 million men and 3.6 million women. These diseases account for roughly 27% of all fatalities in the UK, culminating in over 170,000 deaths every year or around 480 deaths daily. This breaks down to one death every three minutes. As such, the cardiac prosthetic devices market's growth is propelled by the prevalence of cardiovascular diseases.

Get Your Cardiac Prosthetic Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/cardiac-prosthetic-devices-global-market-report

What is the future CAGR of the cardiac prosthetic devices market, and how will it impact industry expansion?
The market size for cardiac prosthetic devices has seen a significant escalation in recent years. The value will increase from $8.2 billion in 2024 to $9.15 billion in 2025, marking a compound annual growth rate (CAGR) of 11.5%. The exponential growth observed during the historical period is due to an increasing number of older individuals with higher instances of cardiovascular diseases, a surge in the occurrence of cardiovascular diseases, enhancement of surgical methodologies, amplified consciousness about cardiac health among patients and healthcare providers, and encouraging government policies and financial assistance for cardiovascular health initiatives.

Anticipations indicate a robust expansion in the cardiac prosthetic device market in the coming years. The market is projected to enhance to $13.97 billion by 2029, portraying a compound annual growth rate (CAGR) of 11.2%. Factors contributing to growth in the prediction period encompass the rise in the elderly demographic susceptible to cardiac ailments, amplified investments in healthcare provision and devices, supportive insurance and repayment conditions, enlarged preference of patients towards sophisticated therapeutic options, and the escalating prevalence of lifestyle-induced cardiac conditions. Leading trends during the predicted period encase advancements in the manufacture of smaller, more efficient cardiac prosthetic devices meant for minimally invasive methods, progress in biocompatible materials, amalgamation with wearable tech, developments in battery tech, and the application of 3D printing technology.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18283&type=smp

What are the most significant trends transforming the cardiac prosthetic devices market today?
Key players in the cardiac prosthetic devices market are concentrating their efforts on creating innovative technologies like transcatheter pacing systems. These are intended to amplify cardiac performance, minimize procedural intrusiveness and enhance patient results in treating heart rhythm irregularities. A transcatheter pacing system acts as a minimally invasive instrument that can regulate the heart's electrical impulse through catheter implantation,, thus eliminating the necessity for external wires or invasive surgery. To illustrate, Medtronic plc, a medical device company based in Ireland, introduced the Micra AV Transcatheter Pacing System in January 2022. This small, minimally intrusive piece of equipment is tailored to manage bradycardia, or a slow heart rate. The Micra AV TPS provides accurate and dependable pacing for bradycardia patients, using state-of-the-art technology to harmonize pacing with the heartbeat's inherent rhythm. Furthermore, due to its compact size and internal battery, the Micra AV TPS promises extended longevity. Its remote monitoring feature allows healthcare professionals to monitor both the device's performance and the patient's progress more efficiently.

Which key market segments comprise the cardiac prosthetic devices market and drive its revenue growth?
The cardiac prosthetic devices market covered in this report is segmented -

1) By Type: Valves, Pacemakers
2) By Applications: Surgery, Research
3) By End User: Hospitals, Clinics Or Cardiac Centers, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Valves: Mechanical Valves, Tissue Valves, Transcatheter Heart Valves
2) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18283

North America was the largest region in the cardiac prosthetic devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac prosthetic devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the cardiac prosthetic devices market?
Major companies operating in the cardiac prosthetic devices market are Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Terumo Corporation, Edwards Lifesciences Corporation, BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Hansen Medical Inc., Abiomed Inc., LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, ATRICURE INC., CryoLife Inc., LifeTech Scientific Corporation, TTK Healthcare Limited, Venus Medtech (Hangzhou) Inc., Braile Biomedica, Kawasumi Laboratories Inc., St. Jude Medical Inc., Sorin Group, Aortic Innovations Inc., Mic Pacetronixro

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=18283&type=smp

What Is Covered In The Cardiac Prosthetic Devices Global Market Report?

•Market Size Forecast: Examine the cardiac prosthetic devices market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the cardiac prosthetic devices market for a structured understanding.
•Key Players Overview: Analyze major players in the cardiac prosthetic devices market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the cardiac prosthetic devices market.
•Segment Contributions: Evaluate how different segments drive overall growth in the cardiac prosthetic devices market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the cardiac prosthetic devices market.
•Industry Challenges: Identify potential risks and obstacles affecting the cardiac prosthetic devices market.
•Competitive Landscape: Review strategic developments in the cardiac prosthetic devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.